MedPath

To study the prevalence of diabetes in an individual specific body type i.e Prakriti through genetic study

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: E08-E13- Diabetes mellitus
Registration Number
CTRI/2019/05/019029
Lead Sponsor
Ministry of AYUSH govt of India
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Volunteer willing to include them in the study by signing in the informed consent (Annexure-3)

Either sex

Age: 30 years and above

Freshly diagnosed cases of diabetes

Pre-diabetics

Chronic cases with or without complications

Patients on Allopathic medicines

Patients on Ayurvedic / Alternative (diet, lifestyle, drug, procedure, yoga) treatment

Patients taking combination treatment

Exclusion Criteria

Volunteer unwilling to include themselves in the study by signing in the informed consent

Secondary diabetes

Age below 30 years

Hypothyroidism

Pregnancy/lactation

Major co-morbidities like (known / Clinically diagnosed) cases of Cancer, CVA, HIV/AIDS, TB, Acute infection, any other conditions which investigator feels will jeopardize the study

Immuno compromised patients

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence/frequency of different Prakriti individuals in diabetes. <br/ ><br>Correlation between Madhumeha and Prakriti lakshanas with elucidation of specific endophenotype of the disease. <br/ ><br>Correlation of madhumeha endophenotypes with markers of disease progression <br/ ><br>Development of repository of Diabetes type II samples like DNA Serum & Plasma <br/ ><br>Timepoint: 3 years
Secondary Outcome Measures
NameTimeMethod
Correlation of madhumeha endophenotypes with molecular signatures (biochemical, genomic SNP, and gut microbial) associated with Prakriti types <br/ ><br>â?¢Correlation of madhumeha endophenotypes with markers of t2DM disease suceptibilityand progression <br/ ><br>Timepoint: 3 years
© Copyright 2025. All Rights Reserved by MedPath